MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 12501-12510 Newer>
The Motley Fool
February 17, 2006
Selena Maranjian
Brokerages Circumventing Falling Fees Some SMAs might serve some investors well, but study your options carefully before signing up. mark for My Articles 309 similar articles
The Motley Fool
February 17, 2006
Rick Aristotle Munarriz
Best Small Cap: Blue Nile by a Mile In the spirit of the Winter Olympics, here are stock challenges from the publication's writers: The jewelry maven Blue Nile adds a bit more gold. mark for My Articles 113 similar articles
The Motley Fool
February 17, 2006
Rick Aristotle Munarriz
Amazon Takes a Bite The digital revolution is knocking. Amazon will be rolling out a self-branded media player, along with a music subscription service. Apple will eventually need to muster a response. Investors, take note. mark for My Articles 1097 similar articles
The Motley Fool
February 17, 2006
Rick Aristotle Munarriz
A Time for Peace Carl Icahn appears to have come to a truce with Time Warner over his breakup plans. However, a significant show of shareholders siding with Icahn's nominees may also force Time Warner to take a harder look at why it can't seem to get its stock out of the high teens. mark for My Articles 328 similar articles
BusinessWeek
February 27, 2006
Gene G. Marcial
UPS Delivers The Goods United Parcel Service may soon bring shareholders a nice surprise package. mark for My Articles 102 similar articles
BusinessWeek
February 27, 2006
Gene G. Marcial
BlackRock's Sale Will Line PNC's Pockets PNC Financial Services Group is a big winner in the deal between Merrill Lynch and investment manager BlackRock. mark for My Articles 74 similar articles
BusinessWeek
February 27, 2006
Gene G. Marcial
Pozen's Trexima: Going To Market With Glaxo Pozen's Trexima is a new drug for severe headaches that analysts claim is more effective and faster-acting than GlaxoSmithKline's $1 billion-a-year blockbuster Imitrex. mark for My Articles 24 similar articles
The Motley Fool
February 16, 2006
Stephen D. Simpson
Kick Tires Before Buying Goodyear has had to contend with the same kinds of cost inflation that seem to have been affecting everyone who relies upon commodity inputs. In short, this is tough stock to get excited about. mark for My Articles 160 similar articles
The Motley Fool
February 16, 2006
Bill Mann
Who's Paying Your Analyst? The most important part of any analyst report is the disclosure. Buying analysis is a contemptuous use of shareholder capital -- more suited to petty despots than corporate stewards. Investors, beware. mark for My Articles
The Motley Fool
February 16, 2006
Brian Gorman
Daimler's Small Steps The company's strategy in the Chrysler unit -- introducing new vehicles with bold styling -- has helped the American unit's performance. But investors still shouldn't expect miracles. mark for My Articles 365 similar articles
<Older 12501-12510 Newer>    Return to current articles.